Work

Post-marketing safety of tralokinumab: a real-world pharmacovigilance study based on the FDA adverse event reporting system

Year: 2024

Type: article

Study design: Observational Study

Source: Expert Opinion on Drug Safety

DOI: 10.1080/14740338.2024.2410434

Authors: Zeping Yang, Kejing Tang, Jie Chen

Institution: The First Affiliated Hospital, Sun Yat-sen University

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Wu Jieping Medical Foundation

Award: G3359849676

OpenAlex ID: W4402898924

FWCI: 3.816

Cites: 43

Cited by: 5

Related to: 10